Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

Tissue glutathione disulfide (GSSG) was studied as an index of changes in redox state in the striatum. When increased turnover of dopamine was provoked in mice by injection of haloperidol (1 mg/kg), the concentration of GSSG in the striatum tripled. Deprenyl (2.5 mg/kg) suppressed the rise in GSSG by 71.9%. These results indicate that deprenyl suppresses an oxidant stress associated with increased dopamine turnover.

[1]  G. Cohen,et al.  Dopamine turnover and glutathione oxidation: implications for Parkinson disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Cohen,et al.  Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione. , 1988, The Journal of pharmacology and experimental therapeutics.

[3]  S. Love,et al.  Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies , 1988, Journal of neuropathology and experimental neurology.

[4]  R. Duvoisin,et al.  Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. , 1988, European journal of pharmacology.

[5]  P. Seeman.  The Biochemical Basis of Neuropharmacology, 5th ed , 1987 .

[6]  R. Lewin.  Drug trial for Parkinson's. , 1987, Science.

[7]  A. Slivka,et al.  Reduced and oxidized glutathione in human and monkey brain , 1987, Neuroscience Letters.

[8]  Arthur J. L. Cooper,et al.  Glutathione and Ascorbate During Ischemia and Postischemic Reperfusion in Rat Brain , 1980, Journal of neurochemistry.

[9]  R. Wurtman,et al.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization , 1980, Brain Research.

[10]  K Berry,et al.  FREE AMINO ACIDS AND RELATED COMPOUNDS IN BIOPSIES OF HUMAN BRAIN , 1971, Journal of neurochemistry.

[11]  M. Yahr,et al.  Clinical Actions of l-Deprenyl in Parkinson’s Disease , 1989 .

[12]  S J Kish,et al.  Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.

[13]  G. Cohen.  Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. , 1987, Advances in neurology.